Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOmarker-guided Treatment Decisions In Psoriatic and Rheumatoid Arthritis: A Feasibility Study

NCT03853395 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT03853395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03853395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOmarker-guided Treatment Decisions In Psoriatic and Rheumatoid Arthritis: A Feasibility Study
Lead sponsor
University of Manchester
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2019
Completion date
May 7, 2025
Enrollment
52 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid